Glenmark Pharmaceuticals Shareholders Approve All Resolutions at 48th AGM
Glenmark Pharmaceuticals Ltd 路 Annual General Meeting 路 12 Sept 2026, 12:27 am
Glenmark Pharmaceuticals Shareholders Approve All Resolutions at 48th AGM Glenmark Pharmaceuticals Limited announced the conclusion and voting results of its 48th AGM held on 11th Sep'26. Shareholders approved all ordinary and special resolutions with requisite majorities, including the adoption of standalone and consolidated financial statements for the fiscal year ended 31st Mar'26. Members approved a dividend of Rs. 2.50 per equity share with 99.9998% votes in favor, the re-appointment of Non-Executive Director Mrs. Blanche Saldanha (99.7725% in favor), and the ratification of Cost Auditor remuneration for the financial year ending 31st Mar'27.
Original exchange filing (PDF)
More announcements from Glenmark Pharmaceuticals Ltd
- Ichnos Glenmark Innovation (IGI) announces IND submission to US FDA for ISB 2301 路 18 Nov 2026
- Glenmark Pharmaceuticals Inc., USA Launches Authorised Generic of INLYTA (axitinib) Tablets, 1 mg and 5mg 路 16 Nov 2026
- Schedule of Schedule of Analyst/ Institutional Investor Meetings 路 10 Nov 2026
- Initmation of Schedule of Analyst/ Institutional Investor Meetings 路 10 Nov 2026
- Intimation of Schedule of Analyst/ Institutional Investor Meetings 路 10 Nov 2026
- Intimation of Schedule of Analyst / Institutional Investor Meetings 路 10 Nov 2026
- Transcript of the Earnings Call 路 09 Nov 2026
- Audio recording of Q2 FY 2026-27 Earnings Call held on November 06, 2026 路 06 Nov 2026
